VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RDNRadian Group Inc.
$37.50$5.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksRDNFinancials

Radian Group Inc. (RDN) Financials

30Y historyFree accessUpdated daily

Revenue growth has contracted by 3.36% year-over-year, yet the company maintains robust profitability with a combined ratio that remained well below the 100% threshold throughout the observed period.

RDN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.4B1.25B1.29B1.24B1.19B1.33B1.44B1.53B1.27B1.22B1.24B1.19B1.07B749.91M902.74M1.95B417.46M1.31B1.81B201.05M1.33B1.3B1.36B1.28B1.07B906.9M615.4M552.81M483.59M390M222.6M
Revenue Growth %9.47%-3.36%4.04%4.19%-10.41%-7.7%-5.7%19.95%4.21%-1.36%3.79%11.24%43.04%-16.93%-53.65%366.59%-68.21%-27.36%799.29%-84.86%2.3%-4.83%6.63%19.8%17.74%47.37%11.32%14.31%24%75.21%34.42%
Medical Costs & Claims173.71M96.1M63.07M20.54M-231.96M153.62M602.17M265.67M228.03M264.03M340.44M314.72M315.21M591.23M955.68M1.34B1.79B1.46B2.71B1.8B111.61M115.85M121.8M128.5M100.8M84.26M51.47M58.78M58.48M41.8M26.85M
Medical Cost Ratio %12.44%7.7%4.89%1.66%-19.48%11.56%41.82%17.4%17.91%21.61%27.49%26.38%29.38%78.84%105.86%68.91%429.43%111.32%149.67%895.47%8.4%8.92%8.93%10.05%9.44%9.29%8.36%10.63%12.09%10.72%12.06%
Gross Profit1.22B1.15B1.23B1.22B1.42B1.18B837.7M1.26B1.04B957.6M898.01M878.53M757.48M158.67M-52.94M605.65M-1.38B-148.73M-897.98M-1.6B1.22B1.18B1.24B1.15B967M822.64M563.93M494.03M425.11M348.2M195.75M
Gross Margin %87.56%92.3%95.11%98.34%119.48%88.44%58.18%82.6%82.09%78.39%72.51%73.62%70.62%21.16%-5.86%31.09%-329.43%-11.32%-49.67%-795.47%91.6%91.08%91.07%89.95%90.56%90.71%91.64%89.37%87.91%89.28%87.94%
Gross Profit Growth %--6.23%0.62%-14.24%21.04%40.31%-33.58%20.7%9.12%6.64%2.22%15.98%377.38%399.75%-108.74%144.04%-824.64%83.44%43.85%-231.49%2.88%-4.82%7.95%19%17.55%45.88%14.15%16.21%22.09%77.88%37.66%
Operating Expenses473.32M387.5M456.29M452.56M469.91M410.56M358.26M412.29M360.79M610.86M414.32M440.7M350.32M332.02M219.49M237.14M204.43M93.55M-223.85M469.61M403.07M441.96M516.6M619.2M365.7M317.14M211.43M274.57M227.19M0113.17M
OpEx / Revenue %33.91%31.07%35.35%36.48%39.46%30.89%24.88%27%28.34%50%33.45%36.93%32.66%44.27%24.31%12.17%48.97%7.12%-12.38%233.58%30.35%34.05%37.87%48.41%34.25%34.97%34.36%49.67%46.98%0%50.84%
Depreciation & Amortization29.3M43.68M78.75M88.92M76.58M75.47M71.73M72.73M69.09M85.83M71.02M81.63M65.95M69.73M53.26M63.12M39.79M20.08M16.19M19.33M37M39.59M32.34M17.31M796K2.49M54.63M2.29M58.5M41.8M26.9M
Combined Ratio %46.35%38.77%40.24%38.14%19.98%42.45%66.7%44.4%46.25%71.62%60.94%63.31%62.04%123.12%130.18%81.08%478.4%118.45%137.29%1129.05%38.76%42.97%46.8%58.45%43.69%44.26%42.72%60.3%59.07%10.72%62.9%
Operating Income748.37M763.15M771.29M767.49M952.78M764.83M479.44M848.99M684.19M346.74M483.69M437.83M407.16M-173.35M-272.43M368.51M-1.58B-242.28M-674.13M-2.07B813.27M740.34M725.6M531.5M601.3M505.5M352.5M219.47M197.91M348.2M82.58M
Operating Margin %53.61%61.19%59.76%61.86%80.02%57.55%33.3%55.6%53.75%28.38%39.06%36.69%37.96%-23.12%-30.18%18.92%-378.4%-18.45%-37.29%-1029.05%61.24%57.03%53.2%41.55%56.31%55.74%57.28%39.7%40.93%89.28%37.1%
Operating Income Growth %--1.06%0.5%-19.45%24.57%59.53%-43.53%24.09%97.32%-28.31%10.47%7.53%334.88%36.37%-173.93%123.33%-552.01%64.06%67.42%-354.39%9.85%2.03%36.52%-11.61%18.95%43.4%60.62%10.89%-43.16%321.68%-41.93%
EBITDA798.27M806.83M850.04M856.4M1.03B840.3M551.17M921.72M753.28M432.57M554.7M519.45M473.11M-103.62M-219.17M431.63M-1.54B-222.2M-657.94M-2.05B850.26M779.93M757.94M548.81M602.1M507.99M407.13M221.75M256.41M390M109.47M
EBITDA Margin %57.19%64.69%65.86%69.03%86.45%63.23%38.28%60.36%59.17%35.41%44.79%43.53%44.1%-13.82%-24.28%22.16%-368.87%-16.92%-36.39%-1019.43%64.03%60.08%55.57%42.9%56.39%56.01%66.16%40.11%53.02%100%49.18%
Interest Expense63.65M65.56M103.74M89.69M84.45M84.46M71.15M56.31M61.49M62.76M81.13M91.1M90.46M74.62M51.83M61.39M41.78M46.01M53.51M53.07M48.15M43.04M34.7M37.5M28.8M17.8M00000
Non-Operating Income-63.65M-65.56M-103.74M-89.69M-84.45M-84.46M-71.15M-56.31M-61.49M-62.76M-81.13M-91.1M-90.46M-74.62M-51.83M-61.39M-41.78M-46.01M-53.51M-53.07M-48.15M-43.04M-34.7M-37.5M-28.8M-17.8M00000
Pretax Income748.37M763.15M771.29M767.49M952.78M764.83M479.44M848.99M684.19M346.74M483.69M437.83M407.16M-173.35M-272.43M368.51M-1.58B-242.28M-674.13M-2.07B813.27M740.34M725.6M531.5M601.3M505.5M352.5M219.47M197.91M159.1M82.58M
Pretax Margin %53.61%61.19%59.76%61.86%80.02%57.55%33.3%55.6%53.75%28.38%39.06%36.69%37.96%-23.12%-30.18%18.92%-378.4%-18.45%-37.29%-1029.05%61.24%57.03%53.2%41.55%56.31%55.74%57.28%39.7%40.93%40.79%37.1%
Income Tax165.31M164.99M166.85M164.37M209.84M164.16M85.81M176.68M78.17M225.65M175.43M156.29M-852.42M-31.5M-48.32M66.36M226.19M-94.4M-263.55M-778.62M231.1M217.49M206.94M145.58M174.11M145.11M103.53M71.33M55.68M43.4M20.35M
Effective Tax Rate %22.09%21.62%21.63%21.42%22.02%21.46%17.9%20.81%11.43%65.08%36.27%35.7%-209.36%18.17%17.74%18.01%-14.32%38.96%39.09%37.63%28.42%29.38%28.52%27.39%28.96%28.71%29.37%32.5%28.13%27.28%24.65%
Net Income562.33M582.8M604.44M603.12M742.93M600.67M393.63M672.31M606.01M121.09M308.25M286.92M959.52M-196.99M-451.47M302.15M-1.81B-147.88M-410.58M-1.29B582.17M522.85M518.7M385.9M427.2M360.4M248.9M148.14M142.24M115.7M62.22M
Net Margin %40.28%46.73%46.83%48.62%62.39%45.2%27.34%44.03%47.6%9.91%24.89%24.05%89.45%-26.27%-50.01%15.51%-432.58%-11.26%-22.71%-641.78%43.84%40.28%38.03%30.17%40.01%39.74%40.45%26.8%29.41%29.67%27.95%
Net Income Growth %-5.75%-3.58%0.22%-18.82%23.68%52.6%-41.45%10.94%400.47%-60.72%7.43%-70.1%587.1%56.37%-249.42%116.73%-1121.18%63.98%68.18%-321.64%11.34%0.8%34.41%-9.67%18.54%44.8%68.02%4.15%22.94%85.95%22.48%
EPS (Diluted)4.064.143.923.774.353.162.003.202.770.551.371.224.10-1.18-3.412.26-15.74-1.80-5.12-16.227.085.915.333.924.273.923.261.921.861.501.27
EPS Growth %4.33%5.61%3.98%-13.33%37.66%58%-37.5%15.52%403.64%-59.85%12.3%-70.24%447.46%65.4%-250.88%114.36%-774.44%64.84%68.43%-329.1%19.8%10.88%35.97%-8.2%8.93%20.25%69.79%3.23%24%18.11%20.95%
EPS (Basic)-4.183.963.814.423.192.013.222.830.561.461.445.20-1.14-3.412.28-15.74-1.80-5.12-16.227.166.105.554.134.574.033.311.961.941.551.28
Diluted Shares Outstanding138.49M138M154.19M160.13M170.66M190.26M196.64M210.34M218.55M220.41M229.26M246.33M233.9M166.37M132.53M133.86M114.7M82.16M80.26M79.56M82.26M88.75M97.9M98.5M99.5M92M76.3M75.63M49.04M48.98M48.88M

Key Metrics

Growth RegimeContracting
ProfitabilityStrong
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Housing market cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Growth Facing Cyclical Headwinds

As reported in financial statements, Radian's revenue growth has shifted into negative territory, with a -3.36% year-over-year contraction reflecting the broader mortgage origination slowdown that continues to suppress new insurance written across the company's core mortgage segment despite the stability of the existing insurance-in-force book.

The decline in top-line growth appears to be a direct consequence of the high-interest-rate environment, which has significantly reduced mortgage refinancing activity. Investors should monitor whether the persistency of the existing book can continue to offset the lack of new business volume in future quarters.

Underwriting Profitability Remains Highly Resilient

Based on the provided quarterly data, Radian maintains a robust underwriting profile, evidenced by a combined ratio that remained well below the 100% threshold throughout the observed period, peaking at 62.8% in 2026Q1 while consistently demonstrating the company's ability to generate significant underwriting profit.

The low combined ratio suggests that the company's risk selection and pricing models are effectively managing credit exposure. The recent uptick in the loss ratio to 23.1% in 2026Q1 warrants further investigation to determine if this represents a structural shift in default trends or merely a temporary quarterly variance.

Reserve Volatility Masks Underlying Performance

According to the historical income statement data, the company's loss provisions have fluctuated significantly, ranging from a low of $9.1 million in 2024Q1 to a high of $107.9 million in 2026Q1, which suggests that reserve adjustments may be creating noise in the reported quarterly net income figures.

The sharp increase in claims and losses in the most recent quarter may indicate a change in the actuarial outlook for the mortgage portfolio. Analysts should be cautious in interpreting these figures, as the release or strengthening of reserves can significantly distort the perceived profitability of the core insurance operations.

Operating Efficiency Supports Capital Returns

With a debt-to-equity ratio of 0.24%, Radian appears to maintain a conservative capital structure that provides substantial flexibility for shareholder returns, as evidenced by the company's ability to sustain consistent earnings despite the cyclical pressures currently impacting the broader mortgage insurance industry's top-line growth.

The company's operating leverage is clearly visible in the high operating margins, which suggest that the fixed-cost base is well-scaled relative to the recurring premium revenue. This financial positioning appears to prioritize balance sheet strength, potentially insulating the firm from immediate liquidity shocks during periods of housing market volatility.

RDN — Frequently Asked Questions

Quick answers to the most common questions about buying RDN stock.

What was Radian Group Inc.'s (RDN) revenue in 2025?

For fiscal year 2025, Radian Group Inc. (RDN) reported total revenue of $1.25B. This represents a 460.3% increase compared to $222.6M in 1996.

Is Radian Group Inc. (RDN) profitable?

Radian Group Inc. (RDN) is profitable, generating $582.8M in net income for the fiscal year ending 2025 with a net profit margin of 46.7%.

What is Radian Group Inc.'s operating profit margin?

Radian Group Inc. (RDN) reported an operating income of $763.1M, resulting in an operating profit margin of 61.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Radian Group Inc.'s gross profit and gross margin?

Radian Group Inc. (RDN) generated $1.15B in gross profit for the year, representing a gross profit margin of 92.3%. This demonstrates the company's core pricing power and production efficiency.